| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 8 |
| 1 | ASPIRIN 325 MG | 8 |
| 2 | ASPIRIN 81 MG | 8 |
| 3 | ATORVASTATIN CALCIUM | 7 |
| 4 | LEVOTHYROXINE SODIUM | 7 |
| 5 | LISINOPRIL | 7 |
| 6 | ADALIMUMAB | 6 |
| 7 | OLANZAPINE | 6 |
| 8 | PREDNISONE | 6 |
| 9 | SERTRALINE HYDROCHLORIDE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUPHENAZINE DECANOATE | 1 | 0.0023 |
| 1 | DICLOXACILLIN SODIUM | 2 | 0.0022 |
| 2 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 3 | HALOPERIDOL DECANOATE | 2 | 0.0011 |
| 4 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 5 | METHENAMINE HIPPURATE | 1 | 0.0008 |
| 6 | ZIPRASIDONE | 2 | 0.0006 |
| 7 | CLONIDINE TRANSDERMAL SYSTEM | 1 | 0.0005 |
| 8 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 9 | CISATRACURIUM BESYLATE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 1 | Corticosteroid [EPC] | 15 |
| 2 | Benzodiazepine [EPC] | 13 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 8 |
| 4 | Platinum-based Drug [EPC] | 8 |
| 5 | Atypical Antipsychotic [EPC] | 7 |
| 6 | Estrogen [EPC] | 6 |
| 7 | Loop Diuretic [EPC] | 6 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| 9 | Vitamin C [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 3 | Cannabinoid [EPC] | 1 | 0.0001 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Nitrofuran Antibacterial [EPC] | 2 | 0.0001 |
| 6 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 7 | Central alpha-2 Adrenergic Agonist [EPC] | 4 | 0.0001 |
| 8 | Vitamin D Analog [EPC] | 1 | 0.0001 |
| 9 | Insulin [EPC] | 2 | 0.0000 |